194 related articles for article (PubMed ID: 17477969)
1. Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth.
Xie Q; Gan L; Wang J; Wilson I; Li L
Mol Immunol; 2007 Jul; 44(14):3453-61. PubMed ID: 17477969
[TBL] [Abstract][Full Text] [Related]
2. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses.
Lye E; Dhanji S; Calzascia T; Elford AR; Ohashi PS
Eur J Immunol; 2008 Mar; 38(3):870-6. PubMed ID: 18286567
[TBL] [Abstract][Full Text] [Related]
3. Lack of IL-1 Receptor-Associated Kinase-4 Leads to Defective Th1 Cell Responses and Renders Mice Susceptible to Mycobacterial Infection.
Marinho FV; Fahel JS; Scanga CA; Gomes MT; Guimarães G; Carvalho GR; Morales SV; Báfica A; Oliveira SC
J Immunol; 2016 Sep; 197(5):1852-63. PubMed ID: 27439514
[TBL] [Abstract][Full Text] [Related]
4. A critical role for the innate immune signaling molecule IRAK-4 in T cell activation.
Suzuki N; Suzuki S; Millar DG; Unno M; Hara H; Calzascia T; Yamasaki S; Yokosuka T; Chen NJ; Elford AR; Suzuki J; Takeuchi A; Mirtsos C; Bouchard D; Ohashi PS; Yeh WC; Saito T
Science; 2006 Mar; 311(5769):1927-32. PubMed ID: 16574867
[TBL] [Abstract][Full Text] [Related]
5. Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells.
Maekawa Y; Mizue N; Chan A; Shi Y; Liu Y; Dawood S; Chen M; Dawood F; de Couto G; Li GH; Suzuki N; Yeh WC; Gramolini A; Medin JA; Liu PP
Circulation; 2009 Oct; 120(14):1401-14. PubMed ID: 19770394
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses.
Zhang Y; Diao N; Lee CK; Chu HW; Bai L; Li L
Mol Ther; 2020 Jan; 28(1):89-99. PubMed ID: 31607540
[TBL] [Abstract][Full Text] [Related]
7. The interleukin-1 receptor-associated kinase M selectively inhibits the alternative, instead of the classical NFkappaB pathway.
Su J; Zhang T; Tyson J; Li L
J Innate Immun; 2009; 1(2):164-74. PubMed ID: 19809574
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ
Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signaling.
Su J; Xie Q; Wilson I; Li L
Cell Signal; 2007 Jul; 19(7):1596-601. PubMed ID: 17379480
[TBL] [Abstract][Full Text] [Related]
10. Adaptive immune cells temper initial innate responses.
Kim KD; Zhao J; Auh S; Yang X; Du P; Tang H; Fu YX
Nat Med; 2007 Oct; 13(10):1248-52. PubMed ID: 17891146
[TBL] [Abstract][Full Text] [Related]
11. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling.
Kawagoe T; Sato S; Jung A; Yamamoto M; Matsui K; Kato H; Uematsu S; Takeuchi O; Akira S
J Exp Med; 2007 May; 204(5):1013-24. PubMed ID: 17485511
[TBL] [Abstract][Full Text] [Related]
12. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
[TBL] [Abstract][Full Text] [Related]
13. HHX-5, a derivative of sesquiterpene from Chinese agarwood, suppresses innate and adaptive immunity via inhibiting STAT signaling pathways.
Zhu Z; Zhao Y; Huo H; Gao X; Zheng J; Li J; Tu P
Eur J Pharmacol; 2016 Nov; 791():412-423. PubMed ID: 27640747
[TBL] [Abstract][Full Text] [Related]
14. IRAK-4--a shared NF-kappaB activator in innate and acquired immunity.
Suzuki N; Saito T
Trends Immunol; 2006 Dec; 27(12):566-72. PubMed ID: 17046325
[TBL] [Abstract][Full Text] [Related]
15. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase.
Thomas JA; Allen JL; Tsen M; Dubnicoff T; Danao J; Liao XC; Cao Z; Wasserman SA
J Immunol; 1999 Jul; 163(2):978-84. PubMed ID: 10395695
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M.
Rothschild DE; Zhang Y; Diao N; Lee CK; Chen K; Caswell CC; Slade DJ; Helm RF; LeRoith T; Li L; Allen IC
EBioMedicine; 2017 Feb; 15():36-47. PubMed ID: 27939424
[TBL] [Abstract][Full Text] [Related]
17. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
[TBL] [Abstract][Full Text] [Related]
18. Procyanidin dimer B2-mediated IRAK-M induction negatively regulates TLR4 signaling in macrophages.
Sung NY; Yang MS; Song DS; Kim JK; Park JH; Song BS; Park SH; Lee JW; Park HJ; Kim JH; Byun EB; Byun EH
Biochem Biophys Res Commun; 2013 Aug; 438(1):122-8. PubMed ID: 23872113
[TBL] [Abstract][Full Text] [Related]
19. IRAK-M regulates the inhibition of TLR-mediated macrophage immune response during late in vitro Leishmania donovani infection.
Srivastav S; Saha A; Barua J; Ukil A; Das PK
Eur J Immunol; 2015 Oct; 45(10):2787-97. PubMed ID: 26140693
[TBL] [Abstract][Full Text] [Related]
20. Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts.
Chen W; Saxena A; Li N; Sun J; Gupta A; Lee DW; Tian Q; Dobaczewski M; Frangogiannis NG
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2598-608. PubMed ID: 22995519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
